Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Up 160.7% in April

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 70,157 shares, a growth of 160.7% from the April 15th total of 26,910 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 5,024,772 shares, the days-to-cover ratio is presently 0.0 days.

Advanced Medical Isotope Price Performance

Advanced Medical Isotope stock opened at $0.07 on Friday. The stock has a market capitalization of $33.47 million, a PE ratio of -6.78 and a beta of -0.77. Advanced Medical Isotope has a 12 month low of $0.04 and a 12 month high of $0.15. The business has a 50 day simple moving average of $0.08 and a 200-day simple moving average of $0.07.

Advanced Medical Isotope (OTCMKTS:RDGL) last announced its earnings results on Monday, March 30th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million during the quarter.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.